Robert Nelsen - Director, 10%+ Owner at CITY THERAPEUTICS, INC.

Issuer-level insider activity

Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Robert Nelsen since 27 Oct 2025

Reported holdings for Robert Nelsen in CITY THERAPEUTICS, INC.

Form 4 holding Director, 10%+ Owner

CITY THERAPEUTICS, INC.

Security class
Common Stock
Shares / value
13,692,507
Estimated value
Report date
19 Oct 2026
Price
Ownership
By ARCH Venture Fund XII, L.P.
Form 4 holding Director, 10%+ Owner

CITY THERAPEUTICS, INC.

Security class
Stock Option (Right to Buy)
Shares / value
22,649
Estimated value
Report date
15 Oct 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

CITY THERAPEUTICS, INC.

Security class
Series A convertible preferred stock
Shares / value
0
Estimated value
Report date
19 Oct 2026
Price
Ownership
By ARCH Venture Fund XII, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

CITY THERAPEUTICS, INC.

Security class
Series B convertible preferred stock
Shares / value
0
Estimated value
Report date
19 Oct 2026
Price
Ownership
By ARCH Venture Fund XII, L.P.
Underlying class
Common Stock
Underlying amount
Form 4 holding Director, 10%+ Owner

CITY THERAPEUTICS, INC.

Security class
Series Seed convertible preferred stock
Shares / value
0
Estimated value
Report date
19 Oct 2026
Price
Ownership
By ARCH Venture Fund XII, L.P.
Underlying class
Common Stock
Underlying amount

Transaction history for Robert Nelsen in CITY THERAPEUTICS, INC.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .